David Peng

Title: The Innovative Contributions of David Peng

Introduction

David Peng is an accomplished inventor based in Mohegan Lake, NY (US). He has made significant strides in the field of cancer treatment, particularly focusing on LKB1 deficient cancers. His innovative approach combines various therapeutic methods to enhance the effectiveness of immune therapy.

Latest Patents

David Peng holds a patent for a groundbreaking method titled "Combination therapy for treatment of LKB1 deficient cancers." This patent outlines methods for sensitizing LKB1/STK11 deficient cancers to immune therapy. The treatment involves the administration of inhibitors targeting NAMPT, CD38, SHP2, CXCR1/2, HDAC4, and PARP in conjunction with immunotherapy. This innovative approach aims to improve patient outcomes in a challenging area of cancer treatment.

Career Highlights

David Peng is affiliated with New York University, where he contributes to research and development in cancer therapies. His work is characterized by a commitment to advancing medical science and improving treatment options for patients suffering from LKB1 deficient cancers.

Collaborations

David has collaborated with notable colleagues, including Kwok-kin Wong and Jiehui Deng. These partnerships enhance the research efforts and contribute to the development of effective cancer treatments.

Conclusion

David Peng's contributions to cancer treatment through his innovative patent demonstrate his dedication to improving patient care. His work at New York University and collaborations with esteemed colleagues further highlight his impact in the field of medical research.